Burn Clinical Trial - Vitamin E Supplementation in Burned Patients

Status Completed

Clinical Trial Summary

A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn injury and, in the process, decrease the secondary consequences of burn injury, including lung injury and impaired wound healing. This may improve the quality of life of the burn patient by preventing pathophysiology that may result from oxidative stress and may reduce hospital stay. Our research will lay the foundation for the future development of effective, safe, and economic therapeutic interventions to treat burn injury-associated metabolic abnormalities. Also, it will provide the basis for the development of supplemental regulations and pharmacotherapy to treat burn patients with vitamin E. The risks are very reasonable in relation to the anticipated benefits to our subjects because a) vitamin E is a simple vitamin that is abundant and approved for clinical use, and b) the subjects will be monitored consistently for the minimal increased tendency to bleed.

Clinical Trial Description

Please see above. ;

Study Design

Related Conditions & MeSH terms

Burn

Clinical Trial Details

NCT number	NCT01749371
Study type	Interventional
Source	The University of Texas Medical Branch, Galveston
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	February 2013
Completion date	September 2017

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01302457` - Oral Care Study on Burn Patients	N/A
Completed	`NCT02729259` - H2O VR for Burns 2015	N/A
Completed	`NCT01965340` - Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission	N/A
Withdrawn	`NCT01225107` - Effect of Cranberry Extract on Infections in Burn Patients	N/A
Completed	`NCT01983280` - The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients	N/A
Completed	`NCT00591448` - Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients	N/A
Active, not recruiting	`NCT02083900` - Use of Banana Leaf Dressing on Donor Site Wounds	Phase 2
Completed	`NCT00242970` - Hypertrophic Scarring After Facial Burn	Phase 2
Completed	`NCT00585325` - Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes	N/A
Terminated	`NCT00591162` - Bone Disease in Severely Burned Children	Phase 2/Phase 3
Completed	`NCT03183622` - A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial	N/A
Terminated	`NCT02452255` - Fenofibrate and Propranolol in Burn Patients	Phase 2/Phase 3
Completed	`NCT02427659` - VR High Tech Pain Control Burn Wound Care	N/A
Not yet recruiting	`NCT00253279` - Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans	Phase 1
Completed	`NCT04516148` - A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting	Phase 4
Withdrawn	`NCT02029261` - Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury
Completed	`NCT00993889` - Virtual Reality Analgesia During Pediatric Physical Therapy	N/A
Terminated	`NCT01062191` - Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl	N/A
Completed	`NCT02394873` - A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound	Phase 1
Completed	`NCT00239668` - Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors